About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Magi2tm1Key
targeted mutation 1, Charles L Sawyers
MGI:5508897
Summary 3 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Magi2tm1Key/Magi2tm1Key involves: 129S4/SvJae MGI:5688180
hm2
Magi2tm1Key/Magi2tm1Key involves: 129S4/SvJae * C57BL/6 MGI:5688182
ht3
Magi2tm1Key/Magi2+ either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * C57BL/6) MGI:5688181


Genotype
MGI:5688180
hm1
Allelic
Composition
Magi2tm1Key/Magi2tm1Key
Genetic
Background
involves: 129S4/SvJae
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Magi2tm1Key mutation (0 available); any Magi2 mutation (71 available)
phenotype observed in females
phenotype observed in males
N normal phenotype

Magi2tm1Key/Magi2tm1Key mice develop severe and diffuse glomerular extracapillary proliferations with focal epithelial crescent formation

mortality/aging
• on a 129 genetic background, the median survival of homozygotes is 50 days, and all mice die by 3 months of age
• Background Sensitivity: on a mixed (129/B6) genetic background, the median survival is 169 days, and many of these mice live beyond 1 year of age

growth/size/body
• homozygotes appear normal at birth and are born at expected Mendelian ratios but exhibit growth retardation within a few weeks after birth

renal/urinary system
• by 4 weeks of age, the endothelium displays a mild loss of fenestrations
• however, the glomerular basement membrane is of normal thickness
• on a 129 genetic background, homozygotes display progressive proteinuria by 3 weeks of age
• Background Sensitivity: on a mixed (129/B6) genetic background, homozygotes show lower-grade proteinuria with variable age of onset
• homozygotes display a significant increase in the urine albumin/creatinine ratio as early as 10 days of age
• at 5.5 weeks, interstitium shows early fibrosis with only chronic interstitial inflammation
• by 7 weeks of age, tubulointerstitium shows advanced chronic changes with chronic inflammation, tubular atrophy, and interstitial fibrosis
• at 5.5 weeks of age, all proliferative and crescentic lesions observed in mutant glomeruli are exclusively composed of activated (KI67-positive) parietal epithelial cells (PECs), indicating PEC activation and proliferation in response to rapid and severe podocyte loss; a marker for macrophages, CD68, is negative in the cellular crescents
• at 3 weeks of age, a mild reduction in the abundance of podocyte proteins synaptopodin and podocin is observed, consistent with podocyte injury and/or loss
• homozygotes develop a diffuse and progressive podocytopathy
• by 4 weeks of age, homozygotes display severe podocyte injury with diffuse foot process effacement
• at 10 days of age, nephrin protein levels are already profoundly reduced in mutant glomeruli, coinciding with the onset of proteinuria; in contrast, other podocyte proteins, such as podocin and CD2AP, are not altered by 18 days of age
• at 3 weeks of age, nephrin protein expression is almost undetectable in mutant glomeruli, coincident with CIN85 up-regulation
• expression of podocyte marker synaptopodin is markedly reduced at 3 weeks and absent by 5.5 weeks in all glomeruli with extracapillary proliferations, indicating a complete loss of podocytes
• by 4 weeks of age, several podocytes appear hypertrophic and exhibit long, thin extensions of their cell bodies
• by 4 weeks of age, homozygotes display microvillous transformation of the cell membrane
• at 3 weeks of age, homozygotes show a mild increase of extracellular matrix accumulation in the mesangium without glomerular hypercellularity, while the tubulointerstitium appears normal
• homozygotes exhibit an early-onset proliferative and non-inflammatory glomerulopathy that ultimately results in death from renal failure
• by 7 weeks, the majority of glomeruli are globally sclerosed
• by 5.5 weeks, most glomeruli appear severely injured, with a collapsed tuft and marked epithelial cell proliferations, in many cases resembling cellular or fibrocellular crescents; however, no glomerular inflammation or hypercellularity is observed
• by 7 weeks, the majority of glomeruli are globally sclerosed with focal fibrous crescents
• at 5.5 weeks, the tubulointerstitium shows mild interstitial fibrosis
• at 5.5 weeks, the tubulointerstitium shows mild tubular atrophy
• at 5.5 weeks, all homozygotes display tubular protein casts; a few glomeruli are globally or segmentally hyalinized
• by 7 weeks of age, the vast majority of glomeruli are globally hyalinized or sclerosed
• homozygotes die of renal failure by 3 months of age

homeostasis/metabolism
• homozygotes exhibit elevated serum creatinine levels
• homozygotes exhibit elevated blood urea nitrogen (BUN) levels
• on a 129 genetic background, homozygotes display progressive proteinuria by 3 weeks of age
• Background Sensitivity: on a mixed (129/B6) genetic background, homozygotes show lower-grade proteinuria with variable age of onset
• homozygotes display a significant increase in the urine albumin/creatinine ratio as early as 10 days of age

immune system
• at 5.5 weeks, interstitium shows early fibrosis with only chronic interstitial inflammation
• by 7 weeks of age, tubulointerstitium shows advanced chronic changes with chronic inflammation, tubular atrophy, and interstitial fibrosis

cardiovascular system
• by 4 weeks of age, the endothelium displays a mild loss of fenestrations
• however, the glomerular basement membrane is of normal thickness

cellular
• by 4 weeks of age, podocyte injury is accompanied by dilation of the endoplasmic reticulum

nervous system
N
• homozygotes show no morphological abnormalities in brain




Genotype
MGI:5688182
hm2
Allelic
Composition
Magi2tm1Key/Magi2tm1Key
Genetic
Background
involves: 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Magi2tm1Key mutation (0 available); any Magi2 mutation (71 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• on a mixed (129/B6) genetic background, the median survival is 169 days, and many homozygotes live beyond 1 year of age
• Background Sensitivity: on a 129 genetic background, the median survival is 50 days, and all mice die by 3 months of age

renal/urinary system
• on a mixed (129/B6) genetic background, homozygotes show lower-grade proteinuria with variable age of onset
• Background Sensitivity: on the 129 genetic background, homozygotes display progressive proteinuria by 3 weeks of age

homeostasis/metabolism
• only 4 of 14 proteinuric homozygotes display elevated serum creatinine levels
• only 4 of 14 proteinuric homozygotes display elevated BUN levels
• on a mixed (129/B6) genetic background, homozygotes show lower-grade proteinuria with variable age of onset
• Background Sensitivity: on the 129 genetic background, homozygotes display progressive proteinuria by 3 weeks of age




Genotype
MGI:5688181
ht3
Allelic
Composition
Magi2tm1Key/Magi2+
Genetic
Background
either: (involves: 129S4/SvJae) or (involves: 129S4/SvJae * C57BL/6)
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Magi2tm1Key mutation (0 available); any Magi2 mutation (71 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• heterozygous of either genetic background exhibit normal survival and no evidence of proteinuria





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/22/2024
MGI 6.24
The Jackson Laboratory